Let's hope we can make the Journal of Infectious Disease or perhaps even the New England Journal of Medicine (maybe a dream too far...). But being published in a respected PR journal should be invaluable in terms of scientific credibility.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.